BTBruce J. Tromberg

Bruce J. Tromberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bruce J. Tromberg has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    11 Accelerating Diagnostic Innovation for Pandemic Control

    by C. Taylor Gilliland, William Heetderks, Krishna Juluru, Anthony Kirilusha, Tiffani B. Lash, Todd Merchak, Felicia Qashu, Douglas M. Sheeley, Mark Snyder, Andrew Weitz, et al.

    Any serious outbreak of a novel infectious disease requires rapid innovation in testing technologies that can efficiently and accurately screen and diagnose active infection on both the individual and population levels. Delays in diagnostic testing imperil containment of an outbreak and delay control of a pandemic. In response to the dearth of diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the outset of the coronavirus disease 2019 (COVID-19) pandemic, the U.S. National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx) initiative. RADx comprises a suite of programs to support the development, production scale-up, and deployment of SARS-CoV-2 tests across the country. RADx helped create a diagnostic testing ecosystem that is dynamic, distributed, and accessible, and that extends diagnostic testing to the point of care (POC) and into homes, schools, and places of business. This chapter describes the approach and lessons learned through one of the components of RADx, RADx Technology, that sped innovation in the development, commercialization, and implementation of COVID-19 testing. RADx Tech, led by the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB), used an innovation funnel methodology to compress the diagnostic technology development timeline from years to months. This was accomplished by employing expert teams in parallel to address technical, regulatory, clinical, and commercialization requirements and to support the validation, de-risking, scale-up, manufacturing, and deployment of novel SARS-CoV-2 tests. RADx Tech and its partner programs enabled dozens of testing technologies to obtain regulatory authorization, delivered billions of tests into the market, and catalyzed a fundamental shift toward the acceptance and widespread use of self-testing. This program represents a new paradigm by which the NIH, and the federal government writ large, can catalyze medical technology development during a public health emergency.


  • Open Access

    Multimodal analyses of vitiligo skin idenitfy tissue characteristics of stable disease

    by Jessica Shiu, Lihua Zhang, Griffin Lentsch, Jessica L. Flesher, Suoqin Jin, Christopher Polleys, Seong Jin Jo, Craig Mizzoni, Pezhman Mobasher, Jasmine Kwan, et al.

    Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreactive CD8 + T cells. Melanocyte destruction in active vitiligo is mediated by CD8 + T cells, but the persistence of white patches in stable disease is poorly understood. The interaction between immune cells, melanocytes, and keratinocytes in situ in human skin has been difficult to study due to the lack of proper tools. We combine noninvasive multiphoton microscopy (MPM) imaging and single-cell RNA-Seq (scRNA-Seq) to identify subpopulations of keratinocytes in stable vitiligo patients. We show that, compared with nonlesional skin, some keratinocyte subpopulations are enriched in lesional vitiligo skin and shift their energy utilization toward oxidative phosphorylation. Systematic investigation of cell-to-cell communication networks show that this small population of keratinocyte secrete CXCL9 and CXCL10 to potentially drive vitiligo persistence. Pseudotemporal dynamics analyses predict an alternative differentiation trajectory that generates this new population of keratinocytes in vitiligo skin. Further MPM imaging of patients undergoing punch grafting treatment showed that keratinocytes favoring oxidative phosphorylation persist in nonresponders but normalize in responders. In summary, we couple advanced imaging with transcriptomics and bioinformatics to discover cell-to-cell communication networks and keratinocyte cell states that can perpetuate inflammation and prevent repigmentation.


  • Monocular 3D Probe Tracking for Generating Sub-Surface Optical Property Maps from Diffuse Optical Spectroscopic Imaging

    by Robert Amelard, Jesse H. Lam, Brian Hill, Amanda Durkin, Kyle Cutler, Bruce J. Tromberg

    Objective: Diffuse optical spectroscopic imaging (DOSI) is a promising biophotonic technology for clinical tissue assessment, but is currently hampered by difficult wide area assessment. A co-integrative optical imaging system is proposed for dense sub-surface optical property spatial assessment. Methods: The proposed system fuses a co-aligned set of camera frames and diffuse optical spectroscopy measurements to generate spatial sub-surface optical property maps. A 3D rigid body motion estimation model was developed by fitting automatically detected target features to an ${a\ priori}$ geometric model using a single overhead camera. Point-wise optical properties were measured across the tissue using frequency domain photon migration DOSI. The 3D probe trajectory and temporal optical property data were fused to generate a 2D spatial optical property map, which was projected onto the tissue image using pre-calibrated camera parameters. Results: The system demonstrated sub-millimeter positional accuracy (error 0.24±0.35 mm) at different probe speeds (1.0-3.8 cm/s), and displacement accuracy in overhead (-0.42±0.33 mm) and tilted (0.51±0.51 mm) camera orientations. Unstructured scans on a tumor inclusion phantom showed strong contrast under different probe paths, and significant (p<0.001) changes in optical properties in an ${in\ vivo}$ leg cuff occlusion protocol with spatial anatomy localization. Conclusion: The proposed co-integrative optical imaging system generated dense sub-surface optical property distributions across wide tissue areas with sub-millimeter accuracy at different probe speeds and trajectories, and does not require pre-planned probe route for tissue assessment. Significance: This system provides a valuable tool for real-time non-invasive tissue health and cancer screening, and enables longitudinal disease progression assessment through unstructured probe-based optical tissue assessment.